| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,656 |
4,541 |
$0.00 |
| 86480 |
|
391 |
387 |
$0.00 |
| 81003 |
|
41 |
37 |
$0.00 |
| 84100 |
|
43 |
41 |
$0.00 |
| 86703 |
|
876 |
876 |
$0.00 |
| 80061 |
Lipid panel |
2,828 |
2,814 |
$0.00 |
| 82540 |
|
1,086 |
1,063 |
$0.00 |
| 99442 |
|
2,220 |
2,137 |
$0.00 |
| 85610 |
|
758 |
586 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
210 |
210 |
$0.00 |
| 83540 |
|
621 |
612 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
468 |
448 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
334 |
320 |
$0.00 |
| 77062 |
|
167 |
167 |
$0.00 |
| 82274 |
|
266 |
265 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
141 |
141 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
19 |
13 |
$0.00 |
| 82570 |
|
261 |
246 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
575 |
306 |
$0.00 |
| 98966 |
|
16 |
15 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
95 |
49 |
$0.00 |
| 82565 |
|
73 |
70 |
$0.00 |
| 3077F |
|
130 |
127 |
$0.00 |
| 3078F |
|
563 |
532 |
$0.00 |
| 86705 |
|
14 |
14 |
$0.00 |
| 80076 |
|
84 |
82 |
$0.00 |
| 84439 |
|
13 |
12 |
$0.00 |
| 3051F |
|
26 |
26 |
$0.00 |
| 91300 |
|
170 |
170 |
$0.00 |
| 90661 |
|
16 |
16 |
$0.00 |
| 82728 |
|
693 |
683 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,563 |
3,536 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,077 |
2,007 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
999 |
989 |
$0.00 |
| 99441 |
|
847 |
814 |
$0.00 |
| 82607 |
|
429 |
426 |
$0.00 |
| 3074F |
|
417 |
391 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,921 |
3,344 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
9,366 |
7,779 |
$0.00 |
| 82043 |
|
1,086 |
1,063 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
143 |
139 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,627 |
3,121 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,091 |
1,069 |
$0.00 |
| 85652 |
|
263 |
260 |
$0.00 |
| 3075F |
|
156 |
154 |
$0.00 |
| 83735 |
|
1,316 |
1,014 |
$0.00 |
| 85027 |
|
1,126 |
1,058 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,255 |
2,087 |
$0.00 |
| 86780 |
|
84 |
83 |
$0.00 |
| 86706 |
|
67 |
67 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
697 |
695 |
$0.00 |
| 81001 |
|
824 |
765 |
$0.00 |
| 87088 |
|
154 |
142 |
$0.00 |
| 83550 |
|
580 |
571 |
$0.00 |
| 90686 |
|
94 |
94 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
602 |
598 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
120 |
119 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
345 |
331 |
$0.00 |
| 87340 |
|
92 |
91 |
$0.00 |
| 86141 |
|
239 |
237 |
$0.00 |
| 86592 |
|
140 |
140 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
141 |
141 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
128 |
90 |
$0.00 |
| 99443 |
|
1,191 |
1,130 |
$0.00 |
| 3044F |
|
292 |
290 |
$0.00 |
| 82746 |
|
80 |
78 |
$0.00 |
| 1111F |
|
140 |
136 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$0.00 |
| 1220F |
|
110 |
104 |
$0.00 |
| 3079F |
|
80 |
78 |
$0.00 |
| 90656 |
|
34 |
34 |
$0.00 |
| 97010 |
|
17 |
13 |
$0.00 |
| 90674 |
|
13 |
13 |
$0.00 |
| 92250 |
|
14 |
13 |
$0.00 |
| 74174 |
|
15 |
15 |
$0.00 |